Botox jab that may freeze prostate cancer

November 2013
Daily Mail;11/19/2013, p28
BOTOX jabs could tackle prostate cancer. The toxin, best known for 'freezing' forehead wrinkles, is being inves tigated for its effects on cancer and symptoms of an enlarged prostate.


Related Articles

  • Clinical trials in prostatic cancer—interpretations and misinterpretations. Newling, D W W // Prostate Cancer & Prostatic Diseases;1999, Vol. 2 Issue 3, p120 

    New agents and therapies in prostate cancer, as in other diseases, need to be accurately, comprehensively and logically developed. The golden standard, a prospective, randomised phase III study can only be carried out efficiently if phase I and phase II studies have been completed. The advent of...

  • Clinical Trial watch Prostate Cancer.  // Urology Times;Apr2003, Vol. 31 Issue 4, p62 

    Offers information on clinical trials relating to prostate cancer as of April 2003. Inclusion of a phase III randomized study of prostatectomy versus expectant management with palliative therapy in patients with clinically localized prostate cancer; Phase III randomized study of radical...

  • Intermittent versus continuous hormone deprivation in metastatic prostate cancer: preliminary data from an ongoing European study. Mottet, N; Costa, P; Navratil, H // Prostate Cancer & Prostatic Diseases;1999 Supplement 2, Vol. 2 Issue 4, pS2 

    Examines intermittent hormonal therapy as a means of maintaining efficacy and improving tolerance in metastatic prostate cancer. Rationale for intermittent treatment schedules; Discussion of maximal androgen blockade; Details of a clinical trial in Europe.

  • Higher Radiation Doses, Fewer Treatments.  // USA Today Magazine;Oct2011, Vol. 140 Issue 2797, p14 

    The article focuses on the results of a multicenter clinical trial which showed the efficacy and safety of higher doses of stereotactic body radiation therapy (SBRT) that involves fewer treatments to patients with low- to intermediate-risk prostate cancer.

  • For Locally Advanced PCa, Add Radiation. Schieszer, John // Renal & Urology News;Sep2010, Vol. 9 Issue 9, p24 

    The article offers information on the randomized international trial which reveals that standard treatment for men with advanced prostate cancer should be androgen deprivation therapy (ADT) and external beam radiation.

  • Algeta-Bayer Prostate Cancer Metastases Trial is Stopped.  // Bioworld Week;6/13/2011, Vol. 19 Issue 24, p3 

    The article reports on the decision of Algeta A/S to stop the Phase III of its clinical trial for the drug Alpharadin due to its statistically significant efficacy in treating bone marrow metastases in castration-resistant prostate cancer patients.

  • Prostate Cancer Versus Enlarged Prostate.  // Tufts University Health & Nutrition Letter;Nov2001, Vol. 19 Issue 9, p6 

    Compares prostate cancer from an enlarged prostate gland. Symptoms of an enlarged prostate; Key for the cure of prostate cancer; Components of the prostate cancer screening test.

  • Benign prostatic hyperplasia and prostate cancer. Hikal, Ahmed H.; Hikal, Ethel M. // Drug Topics;7/6/98, Vol. 142 Issue 13, p62 

    Provides information on benign prostatic hyperplasia and prostate cancer. How these conditions have distinctive characteristics and are prevalent in men as they increase in age; Description of the prostate; Symptomology of both conditions; How diagnosis for both conditions is ascertained;...

  • Two PSA measures help differentiate prostate cancer from BPH. Kochlanska-Dziurowicz, A.A.; Mielniczuk, M.R. // Geriatrics;Oct98, Vol. 53 Issue 10, p88 

    Reports that according to a Polish study, the differentiation between benign prostatic hyperplasia (BPH) and prostate cancer can be determined by using two methods of prostate specific antigen (PSA) ratio. Identification of the two methods of PSA; Operation of the two different types of PSAs;...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics